Repeated harvest enables efficient production of VSV-GP
Viral products keep gaining importance in multiple therapeutic fields. Considering the scale and production slot limitations, optimizing the outcome of every manufacturing batch is essential to minimize costs and make this therapeutic modality broadly available to patients. Most manufacturing proces...
Saved in:
| Main Authors: | Rebecca Habisch, Peter Neubauer, Jorge Soza-Ried, Eva Puschmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2024.1505338/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perfusion process with tangential flow filtration for oncolytic VSV-GP production
by: Orsolya Hamusics, et al.
Published: (2025-05-01) -
Characterization of VSV-GP morphology by cryo-EM imaging and SEC-MALS
by: Dongyue Xin, et al.
Published: (2025-03-01) -
RNAi Screening in Tumor Cells Identifies Artificial microRNAs That Improve Oncolytic Virus Replication
by: Hannah Klemets, et al.
Published: (2025-05-01) -
The Small GTPase Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Vesicular Stomatitis Virus
by: Karen Geoffroy, et al.
Published: (2024-12-01) -
Development of Long-Term Stability of Enveloped rVSV Viral Vector Expressing SARS-CoV-2 Antigen Using a DOE-Guided Approach
by: MD Faizul Hussain Khan, et al.
Published: (2024-10-01)